# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001935979-26-000028
Filing Date
2026-03-13
Accepted
2026-03-13 16:54:52
Documents
19
Period of Report
2026-04-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | bhvn-20260313.htm iXBRL | DEF 14A | 720231
3 |  | bhvn-20260313_g1.jpg | GRAPHIC | 20335
4 |  | bhvn-20260313_g2.jpg | GRAPHIC | 84292
5 |  | bhvn-20260313_g3.jpg | GRAPHIC | 90952
6 |  | bhvn-20260313_g4.jpg | GRAPHIC | 438544
7 |  | bhvn-20260313_g5.jpg | GRAPHIC | 357889
8 |  | bhvn-20260313_g6.jpg | GRAPHIC | 483087
9 |  | bhvn-20260313_g7.jpg | GRAPHIC | 174090
| Complete submission text file | 0001935979-26-000028.txt |  | 4951175

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bhvn-20260313.xsd | EX-101.SCH | 936
21 | EXTRACTED XBRL INSTANCE DOCUMENT | bhvn-20260313_htm.xml | XML | 58033

Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41477 | Film No.: 26753243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)